Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study

Gastric cancer (GC) is frequently diagnosed and treated in advanced tumour stages with poor prognosis. Recent studies have identified isoform 2 of the tight junction protein claudin-18 (CLDN18.2) as a promising target in GC therapy. In this study, we aimed to outline the expression of CLDN18.2 and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dottermusch, Matthias, Krüger, Sandra, Behrens, Hans-Michael, Halske, Christine, Röcken, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861347/
https://www.ncbi.nlm.nih.gov/pubmed/31332522
http://dx.doi.org/10.1007/s00428-019-02624-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861347/
https://www.ncbi.nlm.nih.gov/pubmed/31332522
http://dx.doi.org/10.1007/s00428-019-02624-7

Ejemplares similares